Tyra Biosciences, Inc. — Form D

Tyra Biosciences, Inc. of CARLSBAD, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-13. The offering totals $200.0M, of which $200.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2024-02-13
Form: D
Accession: 0001944599-24-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $200.0M
Amount sold: $200.0M
Investors: 21
Date of first sale: 2024-02-06
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-505161

Issuer

Name: Tyra Biosciences, Inc.
CIK: 0001863127
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 2656 STATE STREET, CARLSBAD, CA, 92008
Phone: (619) 728-4760

Officers, directors & promoters (13)

Name	Role	Location
Isan Chen, M.D.	Director	Carlsbad, CA
Todd Harris, Ph.D.	Director	Carlsbad, CA
Gilla Kaplan, Ph.D.	Director	Rockville, MD
Nina Kjellson	Director	Santa Clara, CA
Melissa McCracken, Ph.D.	Director	Carlsbad, CA
Robert More	Director	Carlsbad, CA
Jake Simson, Ph.D.	Director	Carlsbad, CA
Sid Subramony, Ph.D.	Director	Carlsbad, CA
Rehan Verjee	Director	Carlsbad, CA
Daniel Bensen	Executive Officer	Carlsbad, CA
Alan Fuhrman	Executive Officer	Carlsbad, CA
Todd Harris, Ph.D.	Executive Officer	Carlsbad, CA
Hiroomi Tada, M.D., Ph.D.	Executive Officer	Carlsbad, CA

More